Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.

European journal of neurology2007Láinez MJ, Galván J, Heras J, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2007
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Acute DiseaseAdultCaffeineCross-Over StudiesDouble-Blind MethodDrug Therapy, CombinationErgotamineFemaleHumansMaleMigraine DisordersNauseaPatient SatisfactionPhosphodiesterase InhibitorsPhotophobiaSerotonin Receptor AgonistsTreatment OutcomeTryptaminesVasoconstrictor Agents

DOI 10.1111/j.1468-1331.2006.01594.x

PMID 17355546

View source →